http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 25 Feb 2026 07:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Feb+25/26055125.html si-local-file:///var/storage/secattach/20260225/26055125.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Feb+25/26055125.html Wed, 25 Feb 2026 07:00:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Feb+25/26055125.html si-local-file:///var/storage/secattach/20260225/26055125.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Feb+25/26055125.html Wed, 25 Feb 2026 07:00:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Tiziana+Life+Sciences++++++++++++++++/26036147.html si-local-file:///var/storage/secattach/20260220/26036147.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Tiziana+Life+Sciences++++++++++++++++/26036147.html Fri, 20 Feb 2026 16:11:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Tiziana+Life+Sciences++++++++++++++++/26036147.html si-local-file:///var/storage/secattach/20260220/26036147.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Tiziana+Life+Sciences++++++++++++++++/26036147.html Fri, 20 Feb 2026 16:11:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++AW+++++++++Tiziana+Life+Sciences++++++++++++++++/25877594.html si-local-file:///var/storage/secattach/20260122/25877594.html http://www.streetinsider.com/SEC+Filings/Form++AW+++++++++Tiziana+Life+Sciences++++++++++++++++/25877594.html Thu, 22 Jan 2026 06:02:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++AW+++++++++Tiziana+Life+Sciences++++++++++++++++/25877594.html si-local-file:///var/storage/secattach/20260122/25877594.html http://www.streetinsider.com/SEC+Filings/Form++AW+++++++++Tiziana+Life+Sciences++++++++++++++++/25877594.html Thu, 22 Jan 2026 06:02:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25877595.html si-local-file:///var/storage/secattach/20260122/25877595.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25877595.html Thu, 22 Jan 2026 06:02:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25877595.html si-local-file:///var/storage/secattach/20260122/25877595.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25877595.html Thu, 22 Jan 2026 06:02:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Tiziana+Life+Sciences++++++++++++++++/25870535.html si-local-file:///var/storage/secattach/20260121/25870535.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Tiziana+Life+Sciences++++++++++++++++/25870535.html Wed, 21 Jan 2026 06:01:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Tiziana+Life+Sciences++++++++++++++++/25870535.html si-local-file:///var/storage/secattach/20260121/25870535.html http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++Tiziana+Life+Sciences++++++++++++++++/25870535.html Wed, 21 Jan 2026 06:01:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+20/25866760.html si-local-file:///var/storage/secattach/20260120/25866760.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+20/25866760.html Tue, 20 Jan 2026 11:15:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+20/25866760.html si-local-file:///var/storage/secattach/20260120/25866760.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+20/25866760.html Tue, 20 Jan 2026 11:15:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25859898.html si-local-file:///var/storage/secattach/20260116/25859898.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25859898.html Fri, 16 Jan 2026 15:13:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25859898.html si-local-file:///var/storage/secattach/20260116/25859898.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25859898.html Fri, 16 Jan 2026 15:13:00 -0500 O.00473094 TLSA http://www.streetinsider.com/Equity+Offerings/Tiziana+Life+Sciences+closes+%248.8+million+share+offering/25859761.html <p>Tiziana Life Sciences Ltd. (NASDAQ: TLSA) completed a registered direct offering of 7,040,000 ordinary shares at $1.25 per share, raising $8.8 million in gross proceeds before expenses, according to a company statement.</p> <p>The biotechnology company conducted the offering without an underwriter or placement agent to senior management and existing shareholders. Participants received warrants to purchase additional shares at $1.50 each, exercisable until July 16, 2026, which could generate up to $10.56 million in additional proceeds if fully exercised.</p> <p>Chief Executive Officer Ivor Elrifi purchased 2,400,000 shares, increasing his total holdings to 2,757,848 shares. Executive Chairman and Founder Gabriele Cerrone acquired 1,600,000 shares http://www.streetinsider.com/Equity+Offerings/Tiziana+Life+Sciences+closes+%248.8+million+share+offering/25859761.html Fri, 16 Jan 2026 14:45:48 -0500 O.00473094 TLSA http://www.streetinsider.com/Equity+Offerings/Tiziana+Life+Sciences+closes+%248.8+million+share+offering/25859761.html <p>Tiziana Life Sciences Ltd. (NASDAQ: TLSA) completed a registered direct offering of 7,040,000 ordinary shares at $1.25 per share, raising $8.8 million in gross proceeds before expenses, according to a company statement.</p> <p>The biotechnology company conducted the offering without an underwriter or placement agent to senior management and existing shareholders. Participants received warrants to purchase additional shares at $1.50 each, exercisable until July 16, 2026, which could generate up to $10.56 million in additional proceeds if fully exercised.</p> <p>Chief Executive Officer Ivor Elrifi purchased 2,400,000 shares, increasing his total holdings to 2,757,848 shares. Executive Chairman and Founder Gabriele Cerrone acquired 1,600,000 shares http://www.streetinsider.com/Equity+Offerings/Tiziana+Life+Sciences+closes+%248.8+million+share+offering/25859761.html Fri, 16 Jan 2026 14:45:48 -0500 O.00473094 TLSA http://www.streetinsider.com/Press+Releases/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html <p>BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=HzqZi1lvJdwGJq38j-BrzubYc146aKAu8VeNgR9TYI1xS4kvywheJjzA9-6NareZILN9NpEz52GKeFsOB-RE2BlqWPdS8oy0ab0HdrY7ujlo1Qgz9vO3VcarckXu005P" rel="nofollow" target="_blank">TLSA</a>) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the closing of its previously announced Company best efforts registered direct offering (&quot;Offering&quot;) of 7,040,000 ordinary shares at an offering price of $1.25 per ordinary share conducted without an underwriter or placement agent to members of senior management and existing shareholders. The gross proceeds to Tiziana from the Offering, before deducting estimated Offering expenses payable by Tiziana, were $8.8 million. For every ordinary share subscribed, http://www.streetinsider.com/Press+Releases/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html Fri, 16 Jan 2026 14:45:00 -0500 O.00473094 TLSA http://www.streetinsider.com/Press+Releases/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html <p>BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=HzqZi1lvJdwGJq38j-BrzubYc146aKAu8VeNgR9TYI1xS4kvywheJjzA9-6NareZILN9NpEz52GKeFsOB-RE2BlqWPdS8oy0ab0HdrY7ujlo1Qgz9vO3VcarckXu005P" rel="nofollow" target="_blank">TLSA</a>) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the closing of its previously announced Company best efforts registered direct offering (&quot;Offering&quot;) of 7,040,000 ordinary shares at an offering price of $1.25 per ordinary share conducted without an underwriter or placement agent to members of senior management and existing shareholders. The gross proceeds to Tiziana from the Offering, before deducting estimated Offering expenses payable by Tiziana, were $8.8 million. For every ordinary share subscribed, http://www.streetinsider.com/Press+Releases/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html Fri, 16 Jan 2026 14:45:00 -0500 O.00473094 TLSA http://www.streetinsider.com/Globe+Newswire/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html <p>BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=HzqZi1lvJdwGJq38j-BrzubYc146aKAu8VeNgR9TYI1xS4kvywheJjzA9-6NareZILN9NpEz52GKeFsOB-RE2BlqWPdS8oy0ab0HdrY7ujlo1Qgz9vO3VcarckXu005P" rel="nofollow" target="_blank">TLSA</a>) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the closing of its previously announced Company best efforts registered direct offering (&quot;Offering&quot;) of 7,040,000 ordinary shares at an offering price of $1.25 per ordinary share conducted without an underwriter or placement agent to members of senior management and existing shareholders. The gross proceeds to Tiziana from the Offering, before deducting estimated Offering expenses payable by Tiziana, were $8.8 million. For every ordinary share subscribed, http://www.streetinsider.com/Globe+Newswire/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html Fri, 16 Jan 2026 14:45:00 -0500 O.00473094 TLSA http://www.streetinsider.com/Globe+Newswire/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html <p>BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=HzqZi1lvJdwGJq38j-BrzubYc146aKAu8VeNgR9TYI1xS4kvywheJjzA9-6NareZILN9NpEz52GKeFsOB-RE2BlqWPdS8oy0ab0HdrY7ujlo1Qgz9vO3VcarckXu005P" rel="nofollow" target="_blank">TLSA</a>) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the closing of its previously announced Company best efforts registered direct offering (&quot;Offering&quot;) of 7,040,000 ordinary shares at an offering price of $1.25 per ordinary share conducted without an underwriter or placement agent to members of senior management and existing shareholders. The gross proceeds to Tiziana from the Offering, before deducting estimated Offering expenses payable by Tiziana, were $8.8 million. For every ordinary share subscribed, http://www.streetinsider.com/Globe+Newswire/Tiziana+Life+Sciences+Announces+Closing+of+Oversubscribed+%248.8+Million+Registered+Direct+Offering+of+Ordinary+Shares/25859760.html Fri, 16 Jan 2026 14:45:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25857893.html si-local-file:///var/storage/secattach/20260116/25857893.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25857893.html Fri, 16 Jan 2026 07:40:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25857893.html si-local-file:///var/storage/secattach/20260116/25857893.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++Tiziana+Life+Sciences++++++++++++++++/25857893.html Fri, 16 Jan 2026 07:40:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25857757.html si-local-file:///var/storage/secattach/20260116/25857757.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25857757.html Fri, 16 Jan 2026 07:00:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25857757.html si-local-file:///var/storage/secattach/20260116/25857757.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+16/25857757.html Fri, 16 Jan 2026 07:00:00 -0500 O.00473094 TLSA http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+09/25829071.html si-local-file:///var/storage/secattach/20260109/25829071.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Tiziana+Life+Sciences+++++For%3A+Jan+09/25829071.html Fri, 09 Jan 2026 07:00:00 -0500 O.00473094 TLSA